In August, Turing Pharmaceuticals acquired the drug Daraprim, a 62-year old drug used to treat the parasitic infection toxoplasmosis. Overnight prices of the drug were increased by 5400%. In her Oct. 1 blog post “Going to Plaid: Should Ludicrous Pricing of Life-saving Drugs Be a Crime?” at Mimesis Law, Prof. Jessica Gabel Cino describes how this is not the first time such an increase of a formerly affordable drug has occurred and how there are currently no laws preventing pharmaceutical companies from significantly raising prices of once affordable drugs.
Jessica Gabel Cino is an associate professor of law at Georgia State University College of Law. She teaches courses on forensic evidence, forensic medicine, bankruptcy and contracts. Her primary research focuses on fraud and ethics at the intersection of law and science.